254 related articles for article (PubMed ID: 26239979)
1. Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
Gold B; Roberts J; Ling Y; Quezada LL; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Warren JD; Nathan C
Antimicrob Agents Chemother; 2015 Oct; 59(10):6521-38. PubMed ID: 26239979
[TBL] [Abstract][Full Text] [Related]
2. Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria.
Gold B; Roberts J; Ling Y; Lopez Quezada L; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Nathan C
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060290
[TBL] [Abstract][Full Text] [Related]
3. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
4. Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
Vocat A; Hartkoorn RC; Lechartier B; Zhang M; Dhar N; Cole ST; Sala C
Antimicrob Agents Chemother; 2015 Jul; 59(7):4012-9. PubMed ID: 25896710
[TBL] [Abstract][Full Text] [Related]
5. In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis.
Lounis N; Vranckx L; Gevers T; Kaniga K; Andries K
Med Mal Infect; 2016 Jun; 46(4):220-5. PubMed ID: 27210281
[TBL] [Abstract][Full Text] [Related]
6. Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.
Zhang M; Sala C; Hartkoorn RC; Dhar N; Mendoza-Losana A; Cole ST
Antimicrob Agents Chemother; 2012 Nov; 56(11):5782-9. PubMed ID: 22926567
[TBL] [Abstract][Full Text] [Related]
7. Development of a microdilution method to evaluate Mycobacterium tuberculosis drug susceptibility.
Banfi E; Scialino G; Monti-Bragadin C
J Antimicrob Chemother; 2003 Nov; 52(5):796-800. PubMed ID: 14519676
[TBL] [Abstract][Full Text] [Related]
8. Novel MenA Inhibitors Are Bactericidal against
Berube BJ; Russell D; Castro L; Choi SR; Narayanasamy P; Parish T
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962346
[No Abstract] [Full Text] [Related]
9. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
[TBL] [Abstract][Full Text] [Related]
10. A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
Early JV; Mullen S; Parish T
PLoS One; 2019; 14(10):e0222970. PubMed ID: 31589621
[TBL] [Abstract][Full Text] [Related]
11. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
Darby CM; Nathan CF
J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating
Aher RB; Sarkar D
J Biomol Struct Dyn; 2021 Feb; 39(3):889-900. PubMed ID: 31983295
[TBL] [Abstract][Full Text] [Related]
13. A Novel Small-Molecule Inhibitor of the
Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
[TBL] [Abstract][Full Text] [Related]
14. Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an
de Miranda Silva C; Hajihosseini A; Myrick J; Nole J; Louie A; Schmidt S; Drusano GL
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866874
[TBL] [Abstract][Full Text] [Related]
15. Optimisation of the microplate resazurin assay for screening and bioassay-guided fractionation of phytochemical extracts against Mycobacterium tuberculosis.
O'Neill TE; Li H; Colquhoun CD; Johnson JA; Webster D; Gray CA
Phytochem Anal; 2014; 25(5):461-7. PubMed ID: 24733665
[TBL] [Abstract][Full Text] [Related]
16. Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
Hu Y; Pertinez H; Liu Y; Davies G; Coates A
J Antimicrob Chemother; 2019 Jun; 74(6):1627-1633. PubMed ID: 30789209
[TBL] [Abstract][Full Text] [Related]
17. A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.
Bonnett SA; Dennison D; Files M; Bajpai A; Parish T
PLoS One; 2018; 13(10):e0198059. PubMed ID: 30332412
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
19. Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
Lopez B; Siqueira de Oliveira R; Pinhata JMW; Chimara E; Pacheco Ascencio E; Puyén Guerra ZM; Wainmayer I; Simboli N; Del Granado M; Palomino JC; Ritacco V; Martin A
J Antimicrob Chemother; 2019 Feb; 74(2):373-379. PubMed ID: 30358851
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptor.
Somasundaram S; Anand RS; Venkatesan P; Paramasivan CN
BMC Microbiol; 2013 Oct; 13():218. PubMed ID: 24083570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
